Analyst consensus rating
Fractyl Health Analyst Rating: Strong Buy
GUTS is rated Strong Buy by 6 analysts with a $5.03 target. As of 2026-08-25.
Direct answer
Fractyl Health's consensus rating is Strong Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $5.03.
Forecast evidence checked August 25, 2026.
Get free Fractyl Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.78
- Average price target
- $5.03
- High price target
- $8.00
- Low price target
- $2.00
- Low target gap
- +155.2%
- Target upside
- +542.2%
- High target gap
- +920.7%
- Target range width
- 765.5%
- Consensus rating
- Strong Buy
- Analysts
- 6
- Evidence date
- August 25, 2026
- Valid through
- September 1, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Fractyl Health?
Fractyl Health has a verified Strong Buy consensus. The same dataset has an average price target of $5.03.
How far are Fractyl Health's low and high targets from the recorded price?
The low target implies +155.2%, while the high target implies +920.7%.
How many analysts are included in Fractyl Health's consensus?
The verified consensus includes 6 analysts.
How is Fractyl Health's target upside or downside calculated?
The average target of $5.03 is divided by the recorded price of $0.78, then one is subtracted to produce +542.2%. This does not guarantee a future return.
When was Fractyl Health's analyst forecast verified?
The data was verified on 2026-08-25. The dataset is valid through 2026-09-01.